Drug intelligence / Profile preview

anti-TSPAN5 antibody

Development stage
Preclinical
Lead developer
University of Sheffield
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Anti-TSPAN5 antibody refers to monoclonal antibodies targeting Tetraspanin-5 (TSPAN5), a cell-surface protein belonging to the TspanC8 subfamily. TSPAN5 plays a critical role in regulating the trafficking, maturation, and cell-surface expression of the metalloprotease ADAM10, which in turn activates Notch signaling. In the tumor microenvironment, TSPAN5 is highly expressed by tumor-associated macrophages (TAMs) and promotes mammary tumor growth, invasion, and metastasis. Preclinical research, primarily led by the University of Sheffield and Inserm, has demonstrated that antibody-mediated ablation or knockdown of TSPAN5 can inhibit primary tumor growth, promote a pro-inflammatory macrophage phenotype, and enhance survival in breast cancer models. Additionally, anti-TSPAN5 antibodies have shown potential in inhibiting ligand-induced Notch signaling in other Notch-driven cancers.

Other names
anti-TSPAN5 monoclonal antibodyanti-TSPAN-5 monoclonal antibodyanti-TSPAN 5 monoclonal antibodyanti-Tspan5 antibodyanti-Tspan-5 antibodyanti-Tspan 5 antibodyanti-Tspan5 mAbanti-Tspan-5 mAbanti-Tspan 5 mAbTS5-1rTS-5-1rTS 5-1rTS5-2TS-5-2TS 5-2
02

Targets

TM4SF5 (Tetraspanin 5)

Beyond the preview

Go deeper on anti-TSPAN5 antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-TSPAN5 antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call